CoChat

Potential treatment of Parkinson’s disease with omega-3 polyunsaturated fatty acids

Li, Peng, Song, Cai · 2022 · Nutritional Neuroscience

The DOI matches its Crossref record, with a small difference in title or year; 95 of the 95 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is characterized by dysfunction of the nigrostriatal system, loss of dopamine neurons and intracellular aggregation of α-synuclein. Recently, both clinical and experimental studies have reported that neuroinflammation and oxidative stress markedly contribute to the etiology of PD. Current clinical pharmacotherapies only temporarily relieve the symptoms of PD, accompanied by many side effects. Hence, searching for natural anti-inflammatory, anti-oxidative and neuroprotective agents has received great attention. Polyunsaturated fatty acids (PUFAs), especially omega (n)-3, are essential lipid nutrients in the human diet and important components of cell membranes. Together by competing with the production of n-6 PUFAs, the precursors of inflammatory mediators, n-3 PUFAs can inhibit microglial activity and neuroinflammation, protect astrocyte function to produce neurotrophins, thereby normalizing neurotransmission and improving neurodegeneration. Thus, with regard to the hypotheses of PD, our and other's recent studies have demonstrated that n-3 PUFAs may improve PD by inhibiting proinflammatory cytokine release, promoting neurotrophic factor expression, recovering mitochondrial function and membrane fluidity, decreasing the levels of oxidant production, maintaining α-synuclein proteostasis, calcium homeostasis, axonal transport, and reducing endoplasmic reticulum stress. This review mainly introduces and analyzes the effect of n-3 PUFA treatments on PD-related behavioral and neuropathological abnormalities in clinical patients and different cellular and animal models of PD. Finally, the limitations and future work in n-3 PUFAs anti-PD area are discussed.

Overview

Integrity signals

Registry

Crossref · 10.1080/1028415x.2020.1735143

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Research works printed but not linked: 8

  1. Poewe W, 2017, Nat Rev Dis Primers, 317013
  2. Xia L, 2017, Exp Ther Med, 14, 5569
  3. 10.1186/s40035-015-0042-0 · DOI · Paper page
  4. Watanabe Y, 2005, Med Sci Monit, 11, Ra17
  5. Yang N, 2019, Neurobiol Aging, 76215, e211
  6. Orr SK, 2008, Curr Opin Investig Drugs, 9, 735
  7. Mounsey RB, 2010, Parkinsons Dis, 2011, 1
  8. Wu Y, 2007, Acta Med Okayama, 61, 147

Cited by

See all 74

Metadata

Authors
Li, P., & Song, C.
Affiliations
  • Guangdong Medical College (CN)
  • Guangdong Ocean University (CN)
Corresponding author
Song, Cai
Venue
Nutritional Neuroscience
Published
2020-03-03
Volume
25
Issue
1
Pages
180-191
ISSN
  • 1028-415X (ISSN-L)
  • 1476-8305
OpenAlex
W3010199314
Cited by
74
References
95
Citations by year
2026: 11 · 2025: 11 · 2024: 22 · 2023: 13 · 2022: 11 · 2021: 6
FWCI
0.84
Type
journal article
Language
en
Open access
closed
Locations
  • Nutritional Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
Parkinson's disease, omega-3 polyunsaturated fatty acids, neuroinflammation, oxidative stress, neuroprotection, alpha-synuclein, microglial activation, inflammatory cytokines, neurotrophic factors, mitochondrial function, membrane fluidity, endoplasmic reticulum stress, calcium homeostasis, axonal transport, nigrostriatal pathway, dopaminergic neurons
MeSH terms
Neuroinflammatory Diseases, Animals, Anti-Inflammatory Agents, Antioxidants, Astrocytes, Humans, Nerve Growth Factors, Parkinson Disease, Fatty Acids, Omega-3, Microglia, Oxidative Stress, Neuroprotective Agents, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential treatment of Parkinson’s disease with omega-3 polyunsaturated fatty acids. https://app.cochat.ai/papers/10.1080/1028415x.2020.1735143
The paper
Li, P., & Song, C. (2022). Potential treatment of Parkinson’s disease with omega-3 polyunsaturated fatty acids. Nutritional Neuroscience. https://doi.org/10.1080/1028415x.2020.1735143

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.